ClinicalTrials.gg
Not yet recruitingNCT07917975ORL-CareBOTUpdated Nov 6, 2026

Feasibility Study of a Conversational Chatbot for Outpatient Postoperative Follow-up in Otorhinolaryngology (ENT): Acceptability, Patterns of Use, and Patient Experience.

An interventional study of Post op care evaluation in Surgery Ambulatory, ENT Surgery and Post Surgical Management, sponsored by Fondation Hôpital Saint-Joseph. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Fondation Hôpital Saint-Joseph · Not applicable, Interventional, and Other

Updated Nov 6, 2026Interventions changedNewly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Artificial intelligence (AI), and particularly large language models (LLMs), is playing an increasingly important role in medical practice by facilitating documentation, data analysis, and communication with patients. These tools may improve access to medical information and reduce certain repetitive tasks; however, their use remains limited by risks of errors, hallucinations, variability in responses, and the lack of evaluation in real-world healthcare settings.

In the field of patient-provider communication, several studies have shown that AI-generated responses may be perceived as being as relevant as, or even more empathetic and clearer than, those provided by physicians. However, these findings are based predominantly on simulated scenarios and do not allow conclusions regarding the safety of autonomous use in clinical practice.

Managing patient inquiries outside scheduled consultations represents a substantial workload for healthcare teams. Generative AI could help address this demand, but its implementation requires medical oversight and rigorous safety evaluation.

The postoperative ENT setting provides a relevant area for investigation, as patients frequently experience symptoms that can be difficult to interpret, such as pain, bleeding, or wound-healing complications. A conversational agent could provide consistent responses and continuous accessibility; however, it should never replace on-call medical services. Its primary requirement is the ability to correctly identify situations requiring prompt or urgent medical assessment.

With this objective, a postoperative chatbot was developed using ChatGPT-4 through a secure Retrieval-Augmented Generation (RAG) architecture. Its knowledge base was restricted to recommendations from the French National Authority for Health (HAS), the French Society of Otorhinolaryngology (SFORL), and the PubMed literature in order to improve response reliability. An internal feasibility study yielded encouraging results: 68% of responses were rated as good to excellent by ENT experts, with writing quality and completeness sometimes exceeding those of practicing physicians, although clinicians remained superior in the nuanced assessment of clinical risk.

The objective of the present study is to evaluate the feasibility and acceptability of this ENT postoperative follow-up chatbot among 100 ambulatory surgery patients treated at the Arthur Vernes Institute. The primary aim is to assess the patient experience before evaluating any potential impact on healthcare utilization or medico-economic outcomes.

02

Conditions studied

  • Surgery Ambulatory
  • ENT Surgery
  • Post Surgical Management
03

In context

Lead sponsor

Fondation Hôpital Saint-Joseph is the lead sponsor of 346 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient aged 18 years or older
  • Patient undergoing outpatient ENT surgery at the Arthur Vernes Institute
  • Patient covered by a health insurance scheme
  • French-speaking patient
  • Patient who has provided free, informed, and explicit oral consent

Exclusion criteria

Exclusion Criteria:

  • Patient already enrolled in a Category 1 interventional research protocol (RIPH 1)
  • Patient without access to equipment enabling use of the chatbot (smartphone or computer)
  • Patient under guardianship or curatorship
  • Patient deprived of liberty
  • Patient under judicial protection (safeguard of justice)
  • Pregnant or breastfeeding patient
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Post op Care

    at D30 post surgery, patients will complete 2 scores : Lickert scale and SUS

    Other: Post op care evaluation

Interventions

  • OtherPost op care evaluation

    Patient will be given access to a post surgery Chat Bot. All the questions asked to the chat bot will be analyzed. At D30 patients will complete a likert scale (0 to 5) and the System usabilty score (0 to 100)

06

What researchers measure

Primary outcomes

  1. Determine the effective use of the chatbot

    Proportion of patients having use the chat bot at least once within the 30Days post surgery

    Time frame: up to 30days post surgery

Secondary outcomes

  1. Describe how users can interact with the chatbot.

    number of interaction with the chatbot, topic of the questions

    Time frame: up to 30days post surgery

  2. Assess patient acceptance of the chatbot

    System acceptability scale (from 0 to 100)

    Time frame: 30days post surgery

  3. Assess patient satisfaction

    likert scale (1 to 5)

    Time frame: 30days post surgery

  4. Assess the organizational impact

    number of phone call made during the 30days follow up period after surgery

    Time frame: 30days post surgery

  5. Describe clinical events occurring during the follow-up period

    number of out patient visit and hospital stay during the 30days post surgery follow up period

    Time frame: 30days post surgery

07

Study locations

1 site
  • Institut Arthur Vernes
    Paris, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

2 registry updates since Sep 25, 2026
Interventions
Changed Post op care→Post op care evaluation
Nov 6, 2026
Registered
First appeared on the registry
Nov 5, 2026
Show all 2 updates
  1. Nov 6, 2026
    Interventions Changed Post op care→Post op care evaluation
    + 1 other change: verification date
  2. Nov 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07917975
Responsible party
Sponsor
First posted
Nov 5, 2026
Start date
Dec 2026 (estimated)
Primary completion
Apr 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Nov 6, 2026

Study contacts

juliette courtiade mahler, pHD
Contact
jcourtiade@ghpsj.fr
+33144127963

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion